Search results for "yo"

showing 10 items of 16837 documents

Cystatin C levels are decreased in acute myocardial infarction

2005

Background: Cystatin C is the most abundant protease inhibitor in the plasma. Low plasma levels have been found in patients with aortic aneurysms and they seem correlated with the extension of the aortic lesions in early aneurysms detected by ultrasonography. Methods: In this study, plasma levels of cystatin C have been investigated in patients with acute myocardial infarction (AMI), unstable angina and controls. The effect on plasma levels of the G73A polymorphism of the CST3 gene has been also evaluated. Results: Patients with acute myocardial infarction showed significantly lower levels of cystatin C compared to unstable angina and controls, but levels were nearly normal in a week after …

medicine.medical_specialtybiologyCholesterolbusiness.industryUnstable anginaAcute-phase proteinurologic and male genital diseasesmedicine.diseaseCoronary artery diseasechemistry.chemical_compoundEndocrinologyCystatin CchemistryInternal medicineBlood plasmaCardiologymedicinebiology.proteincardiovascular diseasesGene polymorphismMyocardial infarctionCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Intra-populational and intra-individual mosaicisms of Uranoscopus scaber L. (Perciformes, Uranoscopidae)

1991

Intra-populational and intra-individual mosaicisms of Uranoscopus scaber L. (Perciformes, Uranoscopidae)

medicine.medical_specialtybiologyCytogeneticsZoologyKaryotypeChromosomal translocationbiology.organism_classificationIntra individualPerciformesUranoscopus scaberPolymorphism (computer science)GeneticsmedicineGenetics (clinical)Heredity
researchProduct

Bestimmung der Myokinase und der Kreatin-Phosphokinase im Serum bei experimentellem Lathyrismus, bei Dermatomyositis und bei progressiver Sklerodermie

1965

Mittels einer Bestimmung der muskelspezifischen Fermente Kreatin-Phosphokinase (CPK) und Myokinase (MK) im Serum lathyritischer Ratten wird bei dieser experimentellen akuten Mesenchymschadigung die erhebliche stoffwechselmasige Beteiligung der Muskulatur enzymologisch erfast und dem histomorphologischen Befund in der Skelet-Muskulatur gegenubergestellt.

medicine.medical_specialtybiologyLathyrismbusiness.industryDermatologyGeneral MedicineDermatomyositismedicine.diseaseGastroenterologySclerodermaInternal medicinemedicinebiology.proteinCreatine kinasebusinessArchiv f�r Klinische und Experimentelle Dermatologie
researchProduct

Serum concentrations of collagen degrading enzymes and their inhibitors after downhill running

2001

In the present study the release of proteins degrading extracellular matrix compounds to circulation was measured after damaging exercise in humans. Muscle damage was induced by downhill running; furthermore, the exercise was performed at both cold temperature (5 degrees C) and room temperature (22 degrees C) to study also the possible effect of environmental temperature on serum concentrations of matrix metalloproteinases MMP-2 and MMP-9, tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2, and MMP-2/TIMP-2 complex, and muscle damage monitored by serum creatine kinase measurements. Results were compared with those obtained from patients having rhabdomyolysis, myositis and Becker musc…

medicine.medical_specialtybiologyMatrix metalloproteinase inhibitorChemistryPhysical Therapy Sports Therapy and RehabilitationPhysical exerciseMatrix metalloproteinasemedicine.diseaseExtracellular matrixEndocrinologyBiochemistryInternal medicinemedicinebiology.proteinOrthopedics and Sports MedicineCreatine kinaseMuscular dystrophyRhabdomyolysisMyositisScandinavian Journal of Medicine & Science in Sports
researchProduct

Complete blockade of the vasorelaxant effects of angiotensin-(1-7) and bradykinin in murine microvessels by antagonists of the receptor Mas

2013

Key points • Two distinct angiotensin-(1–7) [Ang-(1–7)] receptor blockers, A779 and d-Pro-Ang-(1–7), can completely prevent Ang-(1–7)-induced vasorelaxation. • Genetic deficiency of Mas completely prevents vascular responses to Ang-(1–7). • Genetic deficiency of Mas completely prevents vascular responses to other NO-dependent vasorelaxants (bradykinin). • Mas plays a key role in NO-mediated vasodilatation by modulating vasorelaxant-mediated phosphorylation of endothelial nitric oxide synthase in endothelial cells. Abstract  The heptapeptide angiotensin-(1–7) is a biologically active metabolite of angiotensin II, the predominant peptide of the renin–angiotensin system. Recently, we have show…

medicine.medical_specialtybiologyPhysiologyBradykininVasodilationAngiotensin IIUmbilical veinNitric oxideNitric oxide synthasechemistry.chemical_compoundEndocrinologychemistryInternal medicinemedicinebiology.proteinBradykinin receptorMyographThe Journal of Physiology
researchProduct

Thromboxane formation by platelets and platelet sensitivity to prostacyclin in patients with acute myocardial infarction

1981

medicine.medical_specialtybiologyThromboxanebusiness.industryProstacyclinHematologymedicine.diseaseInternal medicinemedicineCardiologybiology.proteinPlateletIn patientMyocardial infarctionThromboxane-A synthasebusinessmedicine.drug
researchProduct

ATHEROSCLEROSIS AND MARKERS OF INFLAMMATION IN PATIENTS WITH METABOLIC SYNDROME

2005

medicine.medical_specialtybiologybusiness.industryC-reactive proteinInflammationFibrinogenmedicine.diseaseTunica intimamedicine.anatomical_structureInternal medicineImmunologyInternal Medicinemedicinebiology.proteinCardiologyIn patientMyocardial infarctionmedicine.symptomMetabolic syndromebusinessNational Cholesterol Education Programmedicine.drug
researchProduct

P852Frequency and prognosis of type 2 myocardial infarction vs non ischemic myocardial injury: large observational study from an emergency department

2019

Abstract Background Type 2 Myocardial Infarction (T2MI), due to myocardial oxygen supply-demand mismatch in the absence of atherothrombosis and non-ischemic myocardial injury (NIMI), corresponding to troponin elevation without overt ischemia, are emerging concepts which are suspected to be common in patients hospitalized. However, their respective frequencies, risk profiles and short term prognosis in current routine clinical practice of emergency unit remains to be investigated. Methods Among the medical records of all the patients admitted from January 2014 to December 2016 in a university hospital emergency unit (n=82 543), patients with elevated troponin Ic (≥0.10μg/L) (n=4568) were sys…

medicine.medical_specialtybiologybusiness.industryC-reactive proteinIschemiaEmergency departmentmedicine.diseaseChest painTroponinSystemic inflammatory response syndromeInternal medicinemedicineCardiologybiology.proteinObservational studyMyocardial infarctionmedicine.symptomCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

Stellenwert des Tumormarkers CA 19–9 in der Differentialdiagnose von Raumforderungen im Pankreaskopf

1996

In 96 patients (ductal pancreatic carcinoma, n = 34; periampullary carcinoma, n = 43; chronic pancreatitis, n = 19) the role of CA 19-9 in the diagnosis of lesions of the head of the pancreas were evaluated. The sensitivity for ductal pancreatic carcinoma was 73.3%, for periampullary carcinoma 48.8%, and specificity was 63.2%. Carcinoembryonic antigen was elevated only in every fifth patient. Even when combining the two tumor markers no increase in sensitivity could be observed. The low specificity of 63%, which decreased to 33% in the case of obstructive jaundice, does not allow adequate preoperative differentiation between cancer patients and those with chronic pancreatitis. In cases of p…

medicine.medical_specialtybiologybusiness.industryCancermedicine.diseaseGastroenterologyCarcinoembryonic antigenmedicine.anatomical_structureInternal medicinemedicinebiology.proteinCarcinomaPancreatitisSurgeryCA19-9Differential diagnosisPancreasbusinessTumor markerDer Chirurg
researchProduct

C-reactive protein and family history of myocardial infarction

1999

medicine.medical_specialtybiologybusiness.industryInternal medicineC-reactive proteinbiology.proteinmedicineCardiologyMyocardial infarctionFamily historyCardiology and Cardiovascular Medicinebusinessmedicine.diseaseAtherosclerosis
researchProduct